7 ino –amino -3- [4- piridil -2- tiazol souf Radikal] -3- cephem CAS 400827-6 4- 7

Deskripsyon Product

Non pwodwi: 7 β –amino -3- [4- piridil -2- thiazole souf radikal] -3- cephem CAS NO: 400827-6 4- 7

& nbsp;

& nbsp;

Sinonim:

Pyridinium, {{0}} [2- [[(6R, 7R) -7- amin - {{1}] carboxy -8- oxo {{7 }} thi -1- azabikiklo [4.2. 0] oct - 2- en -3- y] thio] -4- tiazolil] {{8} } - metil, klori, idroklorur (1: 1: 1)

{{0}} (2- {[(6R, 7R) -7- Amino - 2- carboxy -8- oxo -5- th {{8 }} azabikiklo [4.2. 0] oct - 2- en -3- il] sulfanyl} -1, 3- tiazol - {0} } yl) -1- methylpyridinium chloride hydrochloride (1: 1: 1)

& nbsp;

& nbsp;

Chemical & amp; Physical Properties

Aparans: limyè solid jòn.

Tès: ≥99. 0%

& nbsp;

& nbsp;

Nwayo manman an nan cefalolin se materyèl prensipal la anvan tout koreksyon pou sentèz la axetil cefalolin. Mekanis nan anti-bakteri nan cefalolin axetil se konbine ak penisilin obligatwa pwoteyin, ak Lè sa a, jwe yon wòl bakterisid. Li gen gwo anti-bakteri aktivite a gram - pozitif anaerobe, Staphylococcus aureus, strèpokok pneumonie, gram - negatif anaerobe, MRSA ak lòt reziste Gram - bakteri pozitif, epi tou li gen efè inhibition sou Escherichia coli, Haemophilus influenzae, nemokoksik ki reziste penisilin, Klebsiella acidogenes ak Klebsiella pneumoniae. Ceftazidime te devlope pa konpayi Takeda pharmaceutique nan Japon, ak laboratwa yo Forest US te otorize pa mache a. Tankou lòt cefalosporines, yon bag doub ak kat β - bag lactam konbine pou fòme yon bag cephalosporin. Aktivite a nan cefalolin MRSA se akòz li yo - thionitrogen chimik Liv heterocyclic bag. Cefalosporin se dènye jenerasyon céphalosporin. Esè klinik faz III montre ke li gen gwo aktivite anti-bakteri kont MRSA. Eksperyans yo kontwòl montre ke nan tretman an MRSA, pa gen okenn diferans siyifikatif nan efè ki ka geri nan konbinezon de cephalosporin ak vancomycin ak aztreonam. Nan tretman an nan ti zòn akeri nemoni, cefalolin gen menm efè a ka geri tankou ceftriaxone, epi pa gen okenn efè segondè plis. Nan mwa Oktòb 2010, FDA Ameriken an te apwouve lansman yon nouvo tepefaro cepilosporin piki antibyotik devlope pa Takeda pharmaceutique, Japon, pou tretman kominote adilt - akeri nemoni bakteri (CaBP) ak po bakteri egi ak enfeksyon estrikti po ( absssi), ki gen ladan methicillin - rezistan Staphylococcus aureus (MRSA).

& nbsp;

Si ou enterese nan pwodwi nou yo oswa ou gen nenpòt kesyon, tanpri, ezite kontakte nou!

& nbsp;

& nbsp;

Products under patent are offered for R & amp; D purpose only. However, the final responsibility lies exclusively with the buyer.

& nbsp;

Baj popilè: 7 β -amino -3- [4- piridil -2- tiazol radikal souf] -3- cephem cas 400827-6 4- 7, manifaktirè, founisè, faktori, achte, nan stok

• On: (Z)-2-(5-amine-1, 2, 4-thiadiazol-3-yl) -2-ethoxyiminoacetic asid CAS 75028-24-9
• Pwochen: Ceftaroline Fosamil CAS 866021-48-9